Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
3.590
+0.250 (7.49%)
At close: Dec 20, 2024, 4:00 PM
3.610
+0.020 (0.56%)
After-hours: Dec 20, 2024, 7:56 PM EST

Q32 Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21
Revenue
-14.66-6.656.65-
Cost of Revenue
45.9431.7335.8129.93
Gross Profit
-60.6-38.38-29.16-29.93
Selling, General & Admin
16.799.8810.066.76
Operating Expenses
16.799.8810.066.76
Operating Income
-77.39-48.26-39.23-36.69
Interest Expense
-1.3-0.5--
Interest & Investment Income
4.21.2--
Other Non Operating Income (Expenses)
16.45-5.87-3.52-0.32
Pretax Income
-58.73-53.43-42.75-37.02
Income Tax Expense
1.880.320.060.55
Net Income
-60.61-53.74-42.81-37.56
Net Income to Common
-60.61-53.74-42.81-37.56
Shares Outstanding (Basic)
13776
Shares Outstanding (Diluted)
13776
Shares Change (YoY)
548.42%3.25%8.57%-
EPS (Basic)
-4.57-7.41-6.09-5.81
EPS (Diluted)
-5.76-7.41-6.09-5.81
Free Cash Flow
-67.07-18.68-13.44-33.14
Free Cash Flow Per Share
-5.06-2.58-1.91-5.12
Operating Margin
---589.76%-
Profit Margin
---643.65%-
Free Cash Flow Margin
---202.10%-
EBITDA
-76.89-47.76-38.86-36.65
D&A For EBITDA
0.490.50.370.05
EBIT
-77.39-48.26-39.23-36.69
Source: S&P Capital IQ. Standard template. Financial Sources.